Howard Benjamin Insider Trading $RGEN REPLIGEN CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Howard Benjamin.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Howard Benjamin. Howard Benjamin is in REPLIGEN CORP ($RGEN) and VP Business Development in REPLIGEN CORP ($RGEN).

Howard Benjamin in REPLIGEN CORP

Trading Symbol: RGEN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Howard Benjamin: VP Business Development
Holdings: 36,554 shares
Current Value: $1,068,839
Latest Transaction: Dec 18 2017
$RGEN Market Capitalization: $984.14M
$RGEN Previous Close: $29.24

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Howard Benjamin in REPLIGEN CORP

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Dec 18 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Option Exercise	M	26.05	4,062	105,815	8,124
Dec 18 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Option Exercise	M	26.20	6,021	157,750	3,010
Dec 18 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Option Exercise	M	15.91	2,646	42,098	0
Dec 18 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Sell	S	35.34	12,729	449,835	33,908	46.6 K to 33.9 K (-27.29 %)
Dec 18 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Buy	M	26.05	4,062	105,815	46,637	42.6 K to 46.6 K (+9.54 %)
Dec 18 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Buy	M	26.20	6,021	157,750	42,575	36.6 K to 42.6 K (+16.47 %)
Dec 18 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Buy	M	15.91	2,646	42,098	36,554	33.9 K to 36.6 K (+7.80 %)
Mar 22 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Option Exercise	M	6.23	10,000	62,300	0
Mar 22 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Option Exercise	M	15.91	4,968	79,041	0
Mar 22 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Buy	M	6.23	10,000	62,300	33,908	23.9 K to 33.9 K (+41.83 %)
Mar 22 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Sell	S	34.63	7,248	251,010	23,908	31.2 K to 23.9 K (-23.26 %)
Mar 22 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Sell	S	34.61	4,968	171,944	31,156	36.1 K to 31.2 K (-13.75 %)
Mar 22 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Buy	M	15.91	4,968	79,041	36,124	31.2 K to 36.1 K (+15.95 %)
Mar 01 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Option Exercise	A	32.32	9,012	291,268	9,012
Mar 01 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Payment of Exercise	F	32.08	1,976	63,387	31,156	33.1 K to 31.2 K (-5.96 %)
Mar 01 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Grant	A	0.00	4,506	0	33,132	28.6 K to 33.1 K (+15.74 %)
May 26 2016	RGEN	REPLIGEN CORP	Benjamin Howard		Option Exercise	M	6.23	10,000	62,300	10,000
May 26 2016	RGEN	REPLIGEN CORP	Benjamin Howard		Buy	M	6.23	10,000	62,300	28,626	18.6 K to 28.6 K (+53.69 %)
May 13 2016	RGEN	REPLIGEN CORP	Benjamin Howard		Sell	S	26.72	2,889	77,199	18,626	21.5 K to 18.6 K (-13.43 %)
Mar 01 2016	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Option Exercise	A	26.05	12,186	317,445	12,186
Mar 01 2016	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Payment of Exercise	F	26.05	1,302	33,917	21,515	22.8 K to 21.5 K (-5.71 %)
Mar 01 2016	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Grant	A	0.00	6,263	0	22,817	16.6 K to 22.8 K (+37.83 %)
Nov 20 2015	RGEN	REPLIGEN CORP	Benjamin Howard		Option Exercise	M	3.33	5,000	16,650	0
Nov 20 2015	RGEN	REPLIGEN CORP	Benjamin Howard		Buy	M	3.33	5,000	16,650	16,554	11.6 K to 16.6 K (+43.28 %)
Jun 10 2015	RGEN	REPLIGEN CORP	Benjamin Howard		Sell	S	37.48	7,697	288,486	11,554	19.3 K to 11.6 K (-39.98 %)
Jun 10 2015	RGEN	REPLIGEN CORP	Benjamin Howard		Sell	S	38.32	27,303	1,046,368	19,251	46.6 K to 19.3 K (-58.65 %)
Mar 19 2015	RGEN	REPLIGEN CORP	Benjamin Howard		Option Exercise	M	15.91	3,807	60,569	7,614
Mar 19 2015	RGEN	REPLIGEN CORP	Benjamin Howard		Option Exercise	M	6.23	10,000	62,300	20,000
Mar 19 2015	RGEN	REPLIGEN CORP	Benjamin Howard		Sell	S	32.63	15,795	515,443	46,554	62.3 K to 46.6 K (-25.33 %)
Mar 19 2015	RGEN	REPLIGEN CORP	Benjamin Howard		Buy	M	15.91	3,807	60,569	62,349	58.5 K to 62.3 K (+6.50 %)
Mar 19 2015	RGEN	REPLIGEN CORP	Benjamin Howard		Buy	M	6.23	10,000	62,300	58,542	48.5 K to 58.5 K (+20.60 %)
Mar 02 2015	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Option Exercise	A	24.98	9,031	225,594	9,031
Mar 02 2015	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Grant	A	0.00	4,691	0	48,542	43.9 K to 48.5 K (+10.70 %)

Page: 1